Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RAIDEN RESOURCES LIMITED Capital/Financing Update 2003

Oct 5, 2003

65675_rns_2003-10-05_a1332b74-3dbe-46f6-91df-0f020008937a.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement. application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002.

Name of entity

Medical Monitors Limited

ABN

68 009 161 522

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

$\mathbf{1}$ $\pm$ Class of $\pm$ securities issued or to be issued

See Part 3

  • $\overline{2}$ Number of +securities issued or to be issued (if known) or maximum number which may be issued
  • Principal terms of the +securities (eg, $\overline{3}$ if options, exercise price and expiry date; if partly paid *securities, the amount outstanding and due dates payment; if +convertible for securities, the conversion price and dates for conversion)

+ See chapter 19 for defined terms.

Do the +securities rank equally in all $\overline{A}$ respects from the date of allotment with an existing 'class of quoted *securities?

If the additional securities do not rank equally, please state:

  • $\bullet$ the date from which they do
  • $\bullet$ the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment
  • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment
  • Issue price or consideration $\overline{5}$
  • Purpose of the issue 6 (If issued as consideration for the acquisition of assets, clearly identify those assets)

$\overline{\tau}$ Dates of entering +securities into uncertificated holdings $Ol$ despatch of certificates

19 September 2003

+Class Number 1.Ordinary Shares 8 Number and +class of all +securities 1. 143,892,697 quoted on ASX (including the 2. 60,561,113 2. Options (exercisable securities in clause 2 if applicable) at $0.20 each expiring 30/06/05)

+ See chapter 19 for defined terms.

$\overline{9}$ Number and +class of all +securities not quoted on ASX (including the securities in clause 2 if applicable)

1. Restricted preference8,307l.Shares fully paid(MDMAK)2. 22,7702. Restricted preferenceShares fully paid3. 31,077(MDMAQ)3. Restricted preferenceoptions expiring 30 June2005 (MDMAM) Number + Class

$10°$ Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

No dividend policy has been formulated by the company at this stage. It is the Board's intention to defer the development of a dividend policy until surplus cash flows are available.

Part 2 - Bonus issue or pro rata issue

$\mathbf{1}$ securityholderapprovalĬS.required?
$12 \overline{ }$ Is the issue renounceable or non-renounceable?
13 Ratio in which the *securities will beoffered
14 + Class of + securities to which theoffer relates
15 *Recorddeterminedate$\mathfrak{t}$ $\alpha$entitlements
16 Will holdings on different registers(or subregisters) be aggregated forcalculating entitlements?
17 Policy for deciding entitlements inrelation to fractions
18 Names of countries in which theentity has *security holders who willnot be sent new issue documents
Note: Security holders must be told how theirentitlements are to be dealt with.
Cross reference: rale 7.7.

+ See chapter 19 for defined terms.

Appendix 3B New issue announcement

19 ofClosingdateforreceiptacceptances or renunciations
20. Names of any underwriters
21 Amount of any underwriting fee orcommission
22. Names of any brokers to the issue
23. Fee or commission payable to thebroker to the issue
24 handlingAmountanyfeeоfpayable to brokers who lodgeacceptances or renunciations onbehalf of *security holders
25 If the issue is contingent on*security holders' approval, the dateof the meeting
26 Date entitlement and acceptanceform and prospectus or ProductDisclosure Statement will be sent topersons entitled
27 If the entity has issued options, andthe terms entitle option holders toparticipate on exercise, the date onwhich notices will be sent to optionholders
28 Date rights trading will begin (ifapplicable)
29 Date rights trading will end (ifapplicable)
30 How do *security holders sell theirentitlements in full through abroker?
31 How do + security holders sell partof their entitlements through abroker and accept for the balance?

$32°$ How do +security holders dispose of their entitlements (except by sale through a broker)?

33 *Despatch date

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

  • 34 Type of securities $(tick one)$
  • Securities described in Part 1 $(a)$
  • $(b)$ All other securities ⊠

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

(If the additional securities do not form a new class, go to $43$ )

Tick to indicate you are providing the information or documents

35 If the "securities are "equity securities, the names of the 20 largest holders of theadditional "securities, and the number and percentage of additional "securities held bythose holders
36 If the "securities are "equity securities, a distribution schedule of the additional*securities setting out the number of holders in the categories$1 - 1,000$$1,001 - 5,000$$5,001 - 10,000$10,001 - 100,000$100.001$ and over
-37 A copy of any trust deed for the additional *securities

(now go to $43$ )

+ See chapter 19 for defined terms.

Entities that have ticked box 34(b)

  • 38 Number of securities for which 18,869,600 +quotation is sought Class of +securities for which 39 Options quotation is sought (exercisable at $0.20 each expiring 30/06/05) $\overline{\text{Yes}}$ $40$ Do the +securities rank equally in all respects from the date of allotment with an existing 'class of quoted *securities? If the additional securities do not rank equally, please state: • the date from which they do
    • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment
    • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment
  • 41 Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

(if issued upon conversion of another security, clearly identify that other security)

42 Number and +class of all +securities quoted on ASX (including the securities in clause 38)

Number + Class
79,430713 Options(exercisable at $0.20each expiring 30/06/05)

End of restriction period

(now go to $43$ )

$\div$ See chapter 19 for defined terms.

All entities

Fees

43 Payment method (tick one)
$\overline{X}$ Invoice
.
Electronic payment madeNote: Payment may be made electronically if Appendix 3B is given to ASX electronically at the same time.
Periodic payment as agreed with the home branch has been arrangedNote: Arrangements can be made for employee incentive schemes that involve frequent issues of securities.

Quotation agreement

  • $\mathbf{1}$ *Quotation of our additional *securities is in ASX's absolute discretion. ASX may quote the *securities on any conditions it decides.
  • $\overline{\mathcal{L}}$ We warrant the following to ASX.
    • The issue of the *securities to be quoted complies with the law and is not for an illegal purpose.
    • There is no reason why those *securities should not be granted *quotation.
    • An offer of the "securities for sale within 12 months after their issue will not require disclosure under section $707(3)$ or section $1012C(6)$ of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any *securities to be quoted and that no-one has any right to return any *securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the *securities be quoted.
  • We warrant that if confirmation is required under section 1017F of the Corporations Act in relation to the *securities to be quoted, it has been provided at the time that we request that the "securities be quoted.
  • If we are a trust, we warrant that no person has the right to return the *securities to be quoted under section 1019B of the Corporations Act at the time that we request that the "securities be quoted.

+ See chapter 19 for defined terms.

  • $\overline{3}$ We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
  • We give ASX the information and documents required by this form. If any $\overline{4}$ information or document not available now, will give it to ASX before +quotation of the *securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Director

Date: 04/10/03

Sign here:

Print name:

Dr Allan Shell

+ See chapter 19 for defined terms.